These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 23266843)
1. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Blome C; Beikert FC; Rustenbach SJ; Augustin M Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843 [TBL] [Abstract][Full Text] [Related]
2. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients. Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212 [TBL] [Abstract][Full Text] [Related]
3. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K; Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665 [TBL] [Abstract][Full Text] [Related]
4. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842 [TBL] [Abstract][Full Text] [Related]
5. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043 [TBL] [Abstract][Full Text] [Related]
6. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey. Moradi M; Rencz F; Brodszky V; Moradi A; Balogh O; Gulácsi L Arch Iran Med; 2015 Mar; 18(3):153-9. PubMed ID: 25773688 [TBL] [Abstract][Full Text] [Related]
7. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794 [TBL] [Abstract][Full Text] [Related]
8. Hand eczema and health-related quality of life; a comparison of EQ-5D and the Dermatology Life Quality Index (DLQI) in relation to the Hand Eczema Extent Score (HEES). Lindberg M; Bingefors K; Meding B; Berg M Contact Dermatitis; 2013 Sep; 69(3):138-43. PubMed ID: 23948032 [TBL] [Abstract][Full Text] [Related]
9. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis. Pickard AS; Gooderham M; Hartz S; Nicolay C J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948 [TBL] [Abstract][Full Text] [Related]
10. [Assessment of health-related quality of life in psoriasis patients in Hungary]. Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387 [TBL] [Abstract][Full Text] [Related]
11. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III. Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004 [TBL] [Abstract][Full Text] [Related]
12. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Revicki D; Willian MK; Saurat JH; Papp KA; Ortonne JP; Sexton C; Camez A Br J Dermatol; 2008 Mar; 158(3):549-57. PubMed ID: 18047521 [TBL] [Abstract][Full Text] [Related]
13. Comparison of FACT- and EQ-5D-based utility scores in cancer. Pickard AS; Ray S; Ganguli A; Cella D Value Health; 2012; 15(2):305-11. PubMed ID: 22433762 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life among Darier's disease patients. Dodiuk-Gad R; Cohen-Barak E; Ziv M; Shani-Adir A; Amichai B; Zlotogorski A; Shalev S; Rozenman D J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):51-6. PubMed ID: 22121995 [TBL] [Abstract][Full Text] [Related]
15. Mapping from disease-specific measures to health-state utility values in individuals with migraine. Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459 [TBL] [Abstract][Full Text] [Related]
16. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population. Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848 [TBL] [Abstract][Full Text] [Related]
18. Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression. Ali FM; Kay R; Finlay AY; Piguet V; Kupfer J; Dalgard F; Salek MS Qual Life Res; 2017 Nov; 26(11):3025-3034. PubMed ID: 28601958 [TBL] [Abstract][Full Text] [Related]
19. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study. Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B; Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342 [TBL] [Abstract][Full Text] [Related]
20. Health utility measured with EQ-5D in Thai patients undergoing peritoneal dialysis. Sakthong P; Kasemsup V Value Health; 2012; 15(1 Suppl):S79-84. PubMed ID: 22265072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]